Board of Governors

CancerLinQ is governed by a volunteer Board of Governors elected by its sole member, the American Society of Clinical Oncology. The CancerLinQ Chief Executive Officer serves on the Board as well. Board members are not paid for their service, although they receive reimbursement for direct expenses related to the conduct of their Board duties.

View the Disclosures for the Board of Governors below each individual’s name. Please direct any questions related to Board members' disclosures to

  • Carmen Jackson, PMP
    Interim CEO, CancerLinQ

  • Clifford A. Hudis, MD, FACP, FASCO, CEO, Chair 
    View Disclosure

  • Ronald Andrews
    View Disclosure


  • Howard Burris III, MD, FACP, FASCO
    Sarah Cannon
    View Disclosure

  • Eric P. Winer, MD, FASCO
    Yale Cancer Center
    View Disclosure

  • Aaron Sasson

  • Robin Zon, MD, FACP, FASCO
    Michiana Hematology Oncology
    View Disclosure